Ubiquitin proteasome system and the atypical kinase PfPK7 are involved in melatonin signaling in Plasmodium falciparum

Journal of Pineal Research

Volumn 53, Issue 2, 2012, Pages 147-153

  Koyama, Fernanda C ^a   Ribeiro, Ramira Y ^a   Garcia, Julio L ^a   Azevedo, Mauro F ^a   Chakrabarti, Debopam ^b   Garcia, Célia R S ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF CENTRAL FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

kinase; malaria; melatonin; signaling; ubiquitin

Indexed keywords

LUZINDOLE; MELATONIN; PROTEASOME; UBIQUITIN;

ARTICLE; CONTROLLED STUDY; GENE; NONHUMAN; PLASMODIUM FALCIPARUM; PLASMODIUM FALCIPARUM PROTEIN KINASE 7 GENE; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION; WILD TYPE;

ANIMALS; MELATONIN; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; PLASMODIUM FALCIPARUM; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTOZOAN PROTEINS; REAL-TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UBIQUITIN;

EID: 84865016293     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/j.1600-079X.2012.00981.x     Document Type: Article

References (47)

1. Doerig C, Baker D, Billker O, et al., Signalling in malaria parasites. The MALSIG consortium. Parasite 2009; 16: 169-182.
2. Hotta CT, Gazarini ML, Beraldo FH, et al., Calcium-dependent modulation by melatonin of the circadian rhythm in malarial parasites. Nat Cell Biol 2000; 2: 466-468.
3. 2+ release and modulate the cell cycle of Plasmodium falciparum malaria parasites. J Pineal Res 2005; 39: 224-230.
4. Budu A, Peres R, Bueno VB, et al., N1-acetyl-N2-formyl-5- methoxykynuramine modulates the cell cycle of malaria parasites. J Pineal Res 2007; 42: 261-266.
5. Bagnaresi P, Alves E, Da Silva EB, et al., Unlike the synchronous Plasmodium falciparum and P. chabaudi infection, the P. berghei and P. yoelii asynchronous infections are not affected by melatonin. Int J Gen Med 2009; 2: 47-55.
6. Beraldo FH, Almeida FM, Da Silva AM, et al., Cyclic AMP and calcium interplay as second messengers in melatonin-dependent regulation of Plasmodium falciparum cell cycle. J Cell Biol 2005; 170: 551-557.
7. Hotta CT, Markus RP, Garcia CR,. Melatonin and N-acetyl-serotonin cross the red blood cell membrane and evoke calcium mobilization in malarial parasites. Braz J Med Biol Res 2003; 36: 1583-1587.
8. Baker DA, Kelly JM,. Purine nucleotide cyclases in the malaria parasite. Trends Parasitol 2004; 20: 227-232.
9. Caldas ML, Wasserman M,. Cytochemical localisation of calcium ATPase activity during the erythrocytic cell cycle of Plasmodium falciparum. Int J Parasitol 2001; 31: 776-782.
10. Garcia CR, De Azevedo MF, Wunderlich G, et al., Plasmodium in the postgenomic era: new insights into the molecular cell biology of malaria parasites. Int Rev Cell Mol Biol 2008; 266: 85-156.
11. Muhia DK, Swales CA, Eckstein-Ludwig U, et al., Multiple splice variants encode a novel adenylyl cyclase of possible plastid origin expressed in the sexual stage of the malaria parasite Plasmodium falciparum. J Biol Chem 2003; 278: 20014-20022.
12. Nagamune K, Sibley LD,. Comparative genomic and phylogenetic analyses of calcium ATPases and calcium-regulated proteins in the apicomplexa. Mol Biol Evol 2006; 23: 1613-1627.
13. Ono T, Cabrita-Santos L, Leitao R, et al., Adenylyl cyclase alpha and cAMP signaling mediate Plasmodium sporozoite apical regulated exocytosis and hepatocyte infection. PLoS Pathog 2008; 4: e1000008.
14. 2+ transport activity associated with a non-mitochondrial calcium pool in the rodent malaria parasite P. chabaudi. Biochem Mol Biol Int 1997; 42: 919-925.
15. 2+/calmodulin-PfPKB signaling pathway in erythrocyte invasion by Plasmodium falciparum. J Biol Chem 2008; 283: 5589-5597.
16. 2+ pool. Cell Calcium 2003; 33: 137-144.
17. 2+ fluctuations. Biochem Biophys Res Commun 2004; 321: 138-144.
18. Koyama FC, Chakrabarti D, Garcia CR,. Molecular machinery of signal transduction and cell cycle regulation in Plasmodium. Mol Biochem Parasitol 2009; 165: 1-7.
19. Gazarini ML, Beraldo FH, Almeida FM, et al., Melatonin triggers PKA activation in the rodent malaria parasite Plasmodium chabaudi. J Pineal Res 2011; 50: 64-70.
20. Dorin D, Semblat JP, Poullet P, et al., PfPK7, an atypical MEK-related protein kinase, reflects the absence of classical three-component MAPK pathways in the human malaria parasite Plasmodium falciparum. Mol Microbiol 2005; 55: 184-196.
21. Merckx A, Echalier A, Langford K, et al., Structures of P. falciparum protein kinase 7 identify an activation motif and leads for inhibitor design. Structure 2008; 16: 228-238.
22. Dorin-Semblat D, Sicard A, Doerig C, et al., Disruption of the PfPK7 gene impairs schizogony and sporogony in the human malaria parasite Plasmodium falciparum. Eukaryot Cell 2008; 7: 279-285.
23. Reininger L, Tewari R, Fennell C, et al., An essential role for the Plasmodium Nek-2 Nima-related protein kinase in the sexual development of malaria parasites. J Biol Chem 2009; 284: 20858-20868.
24. Hershko A, Ciechanover A,. The ubiquitin system. Annu Rev Biochem 1998; 67: 425-479.
25. Ciechanover A,. The ubiquitin-proteasome pathway: on protein death and cell life. EMBO J 1998; 17: 7151-7160.
26. Bozdech Z, Llinas M, Pulliam BL, et al., The transcriptome of the intraerythrocytic developmental cycle of Plasmodium falciparum. PLoS Biol 2003; 1: E5.
27. Horrocks P, Newbold CI,. Intraerythrocytic polyubiquitin expression in Plasmodium falciparum is subjected to developmental and heat-shock control. Mol Biochem Parasitol 2000; 105: 115-125.
28. Lindenthal C, Weich N, Chia YS, et al., The proteasome inhibitor MLN-273 blocks exoerythrocytic and erythrocytic development of Plasmodium parasites. Parasitology 2005; 131: 37-44.
29. Reynolds JM, El Bissati K, Brandenburg J, et al., Antimalarial activity of the anticancer and proteasome inhibitor bortezomib and its analog ZL3B. BMC Clin Pharmacol 2007; 7: 13.
30. Trager W, Jensen JB,. Human malaria parasites in continuous culture. Science 1976; 193: 673-675.
31. Lambros C, Vanderberg JP,. Synchronization of Plasmodium falciparum erythrocytic stages in culture. J Parasitol 1979; 65: 418-420.
32. Garcia CR, Markus RP, Madeira L,. Tertian and quartan fevers: temporal regulation in malarial infection. J Biol Rythms 2001; 16: 436-443.
33. 2+ signaling in non-excitable cells. Cell Calcium 2003; 34: 431-444.
34. Ponts N, Yang J, Chung DW, et al., Deciphering the ubiquitin-mediated pathway in apicomplexan parasites: a potential strategy to interfere with parasite virulence. PLoS ONE 2008; 3: e2386.
35. Dubocovich ML,. Luzindole (N-0774): a novel melatonin receptor antagonist. J Pharmacol Exp Ther 1988; 246: 902-910.
36. Iengar P, Joshi NV,. Identification of putative regulatory motifs in the upstream regions of co-expressed functional groups of genes in Plasmodium falciparum. BMC Genomics 2009; 10: 18.
37. Cho JW, Kim CW, Lee KS,. Modification of gene expression by melatonin in UVB-irradiated HaCaT keratinocyte cell lines using a cDNA microarray. Oncol Rep 2007; 17: 573-577.
38. Sung JH, Cho EH, Kim MO, et al., Identification of proteins differentially expressed by melatonin treatment in cerebral ischemic injury-a proteomics approach. J Pineal Res 2009; 46: 300-306.
39. Dubocovich ML,. Melatonin receptors: are there multiple subtypes? Trends Pharmacol Sci 1995; 16: 50-56.
40. Wiesenberg I, Missbach M, Carlberg C,. The potential role of the transcription factor RZR/ROR as a mediator of nuclear melatonin signaling. Restor Neurol Neurosci 1998; 12: 143-150.
41. Benitez-King G, Huerto-Delgadillo L, Anton-Tay F,. Binding of 3H-melatonin to calmodulin. Life Sci 1993; 53: 201-207.
42. Bagnaresi P, Nakabashi M, Thomas AP, et al., The role of melatonin in parasite biology. Mol Biochem Parasitol 2011; 181: 1-6.
43. O'donnell AJ, Schneider P, Mcwatters HG, et al., Fitness costs of disrupting circadian rhythms in malaria parasites. Proc Biol Sci 2011; 278: 2429-2436.
44. Bagnaresi P, Markus RP, Hotta CT, Pozzan T, Garcia CRS,. Desynchronizing Plasmodium cell cycle by a melatonin antagonist: a potential therapeutic target in malaria? Int J Gen Med 2008; 2: 55-58.
45. Srinivasan V, Spence DW, Moscovitch A, et al., Malaria: therapeutic implications of melatonin. J Pineal Res 2010; 48: 1-8.
46. Macias M, Rodriguez-Cabezas MN, Reiter RJ, et al., Presence and effects of melatonin in Trypanosoma cruzi. J Pineal Res 1999; 27: 86-94.
47. De Diego JL, Katz JM, Marshall P, et al., The ubiquitin-proteasome pathway plays an essential role in proteolysis during Trypanosoma cruzi remodeling. Biochemistry 2001; 40: 1053-1062.